Related Experiment Video
Updated: Jan 15, 2026
Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Phellodendrine alleviates acute pancreatitis by inhibiting p38 MAPK-p47phox pathway-mediated neutrophil extracellular
Jingjing Zhang1, Pin Li1, Xingmeng Xu1
1Pancreatic Center, Department of Gastroenterology, Yangzhou Key Laboratory of Pancreatic Disease, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China.
Background:
Acute pancreatitis (AP) is an inflammatory disorder of pancreas, where the formation of neutrophil extracellular traps (NETs) plays a crucial role in its pathogenesis. This study examined the therapeutic effect of Phellodendrine (PHE), a Phellodendron-derived alkaloid, on AP by assessing NETs formation and underlying mechanisms.
Methods:
Mouse bone marrow neutrophils were isolated and stimulated to form NETs in vitro to assess PHE's impact. A Caerulein-induced AP mouse model was developed to assess the in vivo efficacy of PHE. Network pharmacology and RNA-seq analysis were utilized to investigate the mechanisms through which PHE alleviates AP. The functional role of the identified target was verified using a p38 inhibitor.
Results:
PHE markedly inhibited NETs formation and reactive oxygen species (ROS) generation in vitro. In vivo experiments further revealed PHE treatment alleviated pancreatic injury and inflammation, which was accompanied by reduced NETs formation and neutrophil infiltration in the mouse of AP. Mechanistically, PHE targeted the p38 MAPK pathway, suppressing its activation and the subsequent membrane translocation of p47phox. Furthermore, co-administration with a p38 inhibitor abolished the inhibitory effects of PHE on NETs formation and ROS production.
Conclusion:
PHE mitigates pancreatic injury and inflammation in AP through its inhibitory effect on NETs formation and ROS production, mediated by targeting the p38 MAPK-p47phox pathway. This indicates its potential as an innovative therapeutic agent for the treatment of AP.
Related Concept Videos
01:27Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
01:30Acute Pancreatitis II: Clinical Manifestations and Management
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
01:30Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...